Big Gain For ImmunoGen, Inc.

Fri, Feb 14, 2020 at 05:30 PM

ImmunoGen, Inc. (IMGN:NASDAQ) soared at $6.8, representing a gain of 26.9%. On Thu 13 Feb 20, IMGN:NASDAQ hit a New 2-Week High of $5.36. The stock got featured on our News Catalysts scanner on Fri 14 Feb 20 at 09:23 AM in the 'GROWTH' category. From Fri 24 Jan 20, the stock recorded 64.29% Up Days and 60.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About ImmunoGen, Inc. (IMGN:NASDAQ)

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

Top 10 Gainers:

Summer Infant, Inc. (SUMR:NASDAQ), 288.03%
Genprex, Inc. (GNPX:NASDAQ), 56.2%
BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 55.01%
Zosano Pharma Corporation (ZSAN:NASDAQ), 38.55%
Digital Ally, Inc. (DGLY:NASDAQ), 34.89%
PAVmed Inc. (PAVM:NASDAQ), 32.26%
ImmunoGen, Inc. (IMGN:NASDAQ), 26.87%
Huitao Technology Co., Ltd. (HHT:NASDAQ), 24.18%
The Chemours Company (CC:NYSE), 23.53%
scPharmaceuticals Inc. (SCPH:NASDAQ), 21.86%